Stocks
Funds
Screener
Sectors
Watchlists
QTRX

QTRX - Quanterix Corp Stock Price, Fair Value and News

$6.68+0.02 (+0.30%)
Market Closed

40/100

QTRX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

40/100

QTRX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$5.79

Target 3M

$6.3

Target 6M

$6.12

QTRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

QTRX Price Action

Last 7 days

-5.2%

Last 30 days

5.0%

Last 90 days

33.6%

Trailing 12 Months

-30.0%

QTRX RSI Chart

QTRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

QTRX Valuation

Market Cap

312.0M

Price/Earnings (Trailing)

-3.26

Price/Sales (Trailing)

2.4

EV/EBITDA

-3.47

Price/Free Cashflow

-4.57

QTRX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$5.79

Target 3M

$6.3

Target 6M

$6.12

QTRX Fundamentals

QTRX Revenue

Revenue (TTM)

130.2M

Rev. Growth (Yr)

12.34%

Rev. Growth (Qtr)

64.38%

QTRX Earnings

Earnings (TTM)

-95.7M

Earnings Growth (Yr)

-301.26%

Earnings Growth (Qtr)

-11.67%

QTRX Profitability

Operating Margin

51.53%

EBT Margin

-77.68%

Return on Equity

-30.41%

Return on Assets

-21.54%

Free Cashflow Yield

-21.86%

QTRX Investor Care

Shares Dilution (1Y)

21.94%

Diluted EPS (TTM)

-2.33

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025135.7M125.8M130.2M0
2024126.0M129.6M133.8M137.4M
2023104.4M111.7M116.6M122.4M
2022112.9M111.0M110.0M105.5M
202197.9M110.1M106.4M110.6M
202060.1M59.7M76.2M86.4M
201942.4M47.3M51.7M56.7M
201825.1M28.5M33.3M37.6M
201718.9M20.2M21.6M22.9M
201600017.6M
QTRX
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
 CEO
 WEBSITEquanterix.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES3200

Quanterix Corp Frequently Asked Questions


QTRX is the stock ticker symbol of Quanterix Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Quanterix Corp is 312.03 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check QTRX's fair value in chart for subscribers.

The fair value guage provides a quick view whether QTRX is over valued or under valued. Whether Quanterix Corp is cheap or expensive depends on the assumptions which impact Quanterix Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for QTRX.

As of Wed Jan 28 2026, QTRX's PE ratio (Price to Earnings) is -3.26 and Price to Sales (PS) ratio is 2.4. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. QTRX PE ratio will change depending on the future growth rate expectations of investors.